The serum prostate-specific antigen (PSA), whose threshold of 4 ng/mL has traditionally been used to detect prostate cancer, is the fundamental of prostate cancer investigation and risk stratification but was negative in our study (6). This evidence concerns the gene KLK3 and Familial prostate cancer.